Please wait

Page 1 of 26

For Immediate Release | Global Communications | MetLife, Inc.

MetLife Announces Full Year and 4Q 2025 Results

Full Year Results

•Net income was $3.2 billion, or $4.71 per share.

•Adjusted earnings per share, excluding total

notable items, up 10%1 to $8.89.

•Premiums, fees and other revenues (PFOs)

increased 10% to $57.6 billion.

•Adjusted PFOs, excluding pension risk transfers

(PRT), were up 5% to $49.8 billion.

•RIS record sales, including transactions of $14.2

billion in PRT and $11.1 billion of U.K. longevity

reinsurance.

•Beat free cash flow ratio and direct expense

ratio2 targets.

•ROE was 12.9%. Adjusted ROE, excluding total

notable items, was 16%, at midpoint of target

range.

•Book value per share (BVPS) up 14% to $39.02.

Adjusted BVPS increased 4% to $57.07.

•Returned nearly $4.4 billion to shareholders.

•Holding company cash and liquid assets totaled

$3.6 billion at year end, within target range.

Fourth Quarter Results

•Net income was $778 million, or $1.17 per share.

•Adjusted earnings increased 13% to $1.6 billion, 

driven by variable investment income, strong

volume growth and improved expense margins.

•Adjusted earnings per share, excluding total

notable items, increased 24% to $2.58.

•PFOs increased 29% to $18.7 billion. Adjusted

PFOs, excluding PRT, up 8% to $12.8 billion.

•Net investment income up 10% to $5.9 billion.

•Variable investment income was $497 million,

primarily reflecting higher private equity returns.

Earnings

Per Share

4Q 2025

Net

Income            $1.17

Adjusted

Earnings          $2.49

Return

on Equity (ROE)

4Q 2025

ROE              12.0%

Adjusted

ROE              17.6%

Comment from Michel Khalaf, President

and Chief Executive Officer:

MetLife delivered record fourth quarter

results, underscoring the strength of our

diversified businesses and the disciplined

execution of our all-weather New Frontier

strategy.

For the full year, we achieved 10%

adjusted earnings per share growth, 16%

adjusted return on equity, and beat our

direct expense and free cash flow ratio

targets, while returning nearly $4.4 billion

to shareholders. We made significant

progress in advancing our New Frontier

priorities, completing key strategic

transactions and entering new

partnerships to extend our market

leadership, expand our global reach, and

enhance capital flexibility.

We are confident that the foundation built

in 2025 positions MetLife to accelerate

growth responsibly and deploy capital

prudently to deliver on our New Frontier

commitments.

1In this news release, all comparisons of results for the fourth quarter of 2025 are with the fourth quarter of 2024, unless otherwise noted. All comparisons of results for the full year

of 2025 are with the full year of 2024, unless otherwise noted. 2 Direct expense ratio, excluding total notable items related to direct expenses and PRT.

Page 2 of 26

Fourth Quarter and Full Year 2025 Summary

($ in millions, except per share data)		Three Months Ended December 31,							Year Ended December 31,
		2025		2024		Change			2025		2024		Change
Premiums, fees and other revenues		$18,696		$14,475		29%			$57,609		$52,520		10%
Net investment income		5,924		5,405		10%			22,559		21,273		6%
Net investment gains (losses)		(160)		(311)					(1,145)		(1,184)
Net derivative gains (losses)		(646)		(903)					(1,939)		(1,623)
Total revenues		$23,814		$18,666					$77,084		$70,986
Adjusted premiums, fees and other revenues		$18,614		$14,437		29%			$57,408		$52,379		10%
Adjusted premiums, fees and other revenues, excluding pension risk transfers (PRT)		$12,839		$11,844		8%			$49,839		$47,530		5%
Market risk benefit remeasurement gains (losses)		$267		$764					$508		$1,109
Net income (loss)		$778		$1,239		(37)%			$3,173		$4,226		(25)%
Net income (loss) per share		$1.17		$1.78		(34)%			$4.71		$5.94		(21)%
Adjusted earnings		$1,648		$1,459		13%			$5,943		$5,796		3%
Adjusted earnings per share		$2.49		$2.09		19%			$8.83		$8.15		8%
Adjusted earnings, excluding total notable items		$1,709		$1,449		18%			$5,986		$5,770		4%
Adjusted earnings, excluding total notable items per share		$2.58		$2.08		24%			$8.89		$8.11		10%
Book value per share		$39.02		$34.28		14%			$39.02		$34.28		14%
Adjusted book value per share		$57.07		$54.81		4%			$57.07		$54.81		4%
Expense ratio		15.4%		17.8%					18.5%		19.0%
Direct expense ratio, excluding total notable items related to direct expenses and PRT		11.6%		13.1%					11.7%		12.1%
Adjusted expense ratio, excluding total notable items related to adjusted other expenses and PRT		20.3%		21.9%					20.1%		20.9%
ROE		12.0%		19.6%					12.9%		16.9%
Adjusted ROE		17.6%		15.4%					15.9%		15.2%
Adjusted ROE, excluding total notable items		18.3%		15.3%					16.0%		15.2%

Information regarding the non-GAAP and other financial measures included in this news release

and reconciliation of the non-GAAP financial measures to GAAP measures are in “Non-GAAP

and Other Financial Disclosures” below and in the tables that accompany this news release.

Page 3 of 26

Supplemental slides for the fourth quarter of 2025, titled “4Q25 Earnings Call Presentation,” are

available on the MetLife Investor Relations website at https://investor.metlife.com and in the

Form 8-K furnished by MetLife to the U.S. Securities and Exchange Commission in connection

with this earnings release. Supplemental information about MetLife's diversified global

investment portfolio is contained in the "4Q25 - General Account Assets Under Management

Fact Sheet," available on the above-mentioned website. Additionally, further information is

available under the heading "Consolidated Company Outlook" in Item 8.01 of the Form 8-K.

Total Company Discussion

MetLife reported fourth quarter 2025 premiums, fees and other revenues of $18.7 billion, up 29

percent compared with the prior-year quarter. Adjusted premiums, fees and other revenues,

excluding pension risk transfers, were $12.8 billion, up 8 percent.

Net investment income was $5.9 billion, up 10 percent, primarily due to higher variable

investment income and increases in the estimated fair value of certain securities that do not

qualify as separate accounts under GAAP. Adjusted net investment income was $5.6 billion, up

5 percent, mainly driven by higher variable investment income.

Net investment losses were $160 million, or $126 million after tax, reflecting normal trading

activity and a stable credit environment. Net derivative losses amounted to $646 million, or

$510 million after tax, due to higher long-term interest rates, stronger equity markets and

strengthening of the U.S. dollar.

Net income decreased 37 percent to $778 million. Net derivative losses and net investment

losses were the primary drivers, partially offset by market risk benefit remeasurement gains and

higher adjusted earnings. On a per-share basis, net income decreased 34 percent to $1.17.

Adjusted earnings were $1.6 billion, up 13 percent on a reported basis and 12 percent on a

constant currency basis. On a per-share basis, adjusted earnings were $2.49, up 19 percent.

MetLife's direct expense ratio, excluding total notable items related to direct expenses and PRT,

was 11.6 percent in the fourth quarter and 11.7 percent for the full year, compared to 13.1

percent in the prior-year quarter and 12.1 percent for the full year 2024.

Page 4 of 26

Adjusted Earnings by Segment Summary

	Three Months Ended December 31, 2025		Year Ended December 31, 2025
Segment	Change from prior-year period (on a reported basis)	Change from prior-year period (on a constant currency basis)	Change from prior year (on a reported basis)	Change from prior year (on a constant currency basis)
Group Benefits	12%		5%
Retirement and Income Solutions (RIS)	18%		—%
Asia	—%	1%	5%	6%
Latin America	(1)%	(9)%	(9)%	(6)%
Europe, the Middle East and Africa (EMEA)	64%	64%	30%	31%
MetLife Investment Management (MIM)	275%		264%

Business Discussions

GROUP BENEFITS

($ in millions)	Three Months Ended December 31, 2025	Three Months Ended December 31, 2024	Change
Adjusted earnings	$465	$416	12%
Notable item(s)	$0	$0
Adjusted earnings ex. notables	$465	$416	12%
Adjusted PFOs	$6,287	$6,184	2%

•Adjusted earnings were $465 million, up 12 percent, largely reflecting favorable life

underwriting.

•Adjusted PFOs were $6.3 billion, up 2 percent. Overall growth was partially offset by the

impact of favorable mortality on participating life contracts. PFOs from participating life

contracts can fluctuate with claims experience.

•Sales were up 4 percent for the full year, primarily driven by regional business growth.

RIS

($ in millions)	Three Months Ended December 31, 2025	Three Months Ended December 31, 2024	Change
Adjusted earnings	$454	$386	18%
Notable item(s)	$0	$0
Adjusted earnings ex. notables	$454	$386	18%
Adjusted PFOs	$7,209	$3,620	99%
Adjusted PFOs, excluding PRT	$1,434	$1,027	40%

•Adjusted earnings were $454 million, up 18 percent, largely driven by favorable variable

investment income.

•Adjusted PFOs were $7.2 billion, mainly reflecting record PRT sales.

•Adjusted PFOs, excluding PRT, were $1.4 billion, up 40 percent, mainly due to U.K.

longevity reinsurance.

Page 5 of 26

•Total liability exposure grew 14 percent, including 13 percent in general account liabilities.

ASIA

($ in millions)	Three Months Ended December 31, 2025	Three Months Ended December 31, 2024	Change	Constant currency change
Adjusted earnings	$444	$443	—%	1%
Notable item(s)	$0	$0
Adjusted earnings ex. notables	$444	$443	—%	1%
Adjusted PFOs	$1,671	$1,635	2%	3%
Asia general account assets under management (at amortized cost)	$140,168	$129,959	8%	7%

•Adjusted earnings were $444 million, essentially flat on a reported basis and up 1 percent

on a constant currency basis. Volume growth and favorable expenses were offset by less

favorable underwriting. 

•Adjusted PFOs were $1.7 billion, up 2 percent on a reported basis, and up 3 percent on a

constant currency basis, reflecting strong growth across the region.

•Asia general account assets under management (at amortized cost) were

$140.2 billion, up 7 percent on a constant currency basis.

•Sales were $598 million, up 18 percent on a constant currency basis, primarily driven by

Japan and Korea.

LATIN AMERICA

($ in millions)	Three Months Ended December 31, 2025	Three Months Ended December 31, 2024	Change	Constant currency change
Adjusted earnings	$198	$201	(1)%	(9)%
Notable item(s)	$(29)	$0
Adjusted earnings ex. notables	$227	$201	13%	4%
Adjusted PFOs	$1,796	$1,438	25%	16%

•Adjusted earnings were $198 million, down 1 percent on a reported basis and down 9

percent on a constant currency basis, primarily reflecting a value-added tax adjustment in

Mexico.

•Excluding notable items, adjusted earnings were $227 million, up 13 percent on a

reported basis and up 4 percent on a constant currency basis, primarily driven by strong

volume growth across the region and favorable Chilean encaje returns.

•Adjusted PFOs were $1.8 billion, up 25 percent on a reported basis and up 16 percent on a

constant currency basis, due to strong growth across the region.

•Sales were $451 million, up 26 percent on a constant currency basis, driven by growth

across the region.

Page 6 of 26

EMEA

($ in millions)	Three Months Ended December 31, 2025	Three Months Ended December 31, 2024	Change	Constant currency change
Adjusted earnings	$97	$59	64%	64%
Notable item(s)	$0	$0
Adjusted earnings ex. notables	$97	$59	64%	64%
Adjusted PFOs	$787	$652	21%	17%

•Adjusted earnings were $97 million, up 64 percent on a reported and constant currency

basis, primarily driven by strong volume growth across the region and favorable

underwriting.

•Adjusted PFOs were $787 million, up 21 percent on a reported basis and up 17 percent on

a constant currency basis, reflecting strong sales across the region.

•Sales were $310 million, up 24 percent on a constant currency basis, reflecting strong

growth across most markets.

METLIFE INVESTMENT MANAGEMENT

($ in millions)	Three Months Ended December 31, 2025	Three Months Ended December 31, 2024	Change
Adjusted earnings	$60	$16	275%
Notable item(s)	$0	$0
Adjusted earnings ex. notables	$60	$16	275%
Other revenues	$239	$181	32%
Total assets under management	$741,674	$585,729	27%
Institutional net flows	$5,612	$5,118	10%

•Adjusted earnings were $60 million compared with $16 million.

•Other revenues were $239 million, up 32 percent.

•Total assets under management were $741.7 billion, up 27 percent, primarily reflecting the

acquisition of PineBridge Investments, which closed on December 30, 2025.

CORPORATE & OTHER

($ in millions)	Three Months Ended December 31, 2025	Three Months Ended December 31, 2024	Change
Adjusted earnings	$(70)	$(62)
Notable item(s)	$(32)	$10
Adjusted earnings ex. notables	$(38)	$(72)

•Adjusted loss of $70 million, compared to an adjusted loss of $62 million.

•Adjusted loss, excluding notable items, of $38 million, compared to an adjusted loss,

excluding notable items, of $72 million.

Page 7 of 26

INVESTMENTS

($ in millions)	Three Months Ended December 31, 2025	Three Months Ended December 31, 2024	Change
Adjusted net investment income	$5,577	$5,301	5%

•Adjusted net investment income was $5.6 billion, up 5 percent. Variable investment

income increased 70 percent to $497 million, primarily driven by higher returns on private

equity assets.

FOURTH QUARTER 2025 NOTABLE ITEMS

($ in millions)	Adjusted Earnings
	Three Months Ended December 31, 2025
Notable Items	Group Benefits	RIS	Asia	Latin America	EMEA	MIM	Corporate & Other	Total
Litigation reserves and settlement costs	$0	$0	$0	$0	$0	$0	$(32)	$(32)
Tax adjustments	$0	$0	$0	$(29)	$0	$0	$0	$(29)
Total notable items	$0	$0	$0	$(29)	$0	$0	$(32)	$(61)

Contacts:      For Media:  Jane Slusark (347) 989-5477, Jane.Slusark@metlife.com

For Investors:   John Hall (212) 578-7888, John.A.Hall@metlife.com

About MetLife

MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the

world’s leading financial services companies, providing insurance, annuities, employee benefits

and asset management to help individual and institutional customers build a more confident

future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds

leading positions in the United States, Asia, Latin America, Europe and the Middle East. For

more information, visit www.metlife.com.

Conference Call

MetLife will hold its combined fourth quarter and full year 2025 earnings and outlook conference

call on Thursday, February 5, 2026, from 9-10 a.m. (ET). The conference call will be available

live via the internet. To listen to the conference call, click the following link to register (https://

events.q4inc.com/attendee/951205562).

The conference call will be available for replay via telephone and the internet beginning at 11:00

a.m. (ET) on Thursday, February 5, 2026, until Thursday, February 12, 2026, at 11:59 p.m. (ET).

To listen to a replay of the conference call via telephone, dial 800-770-2030 (U.S.) or

647-362-9199 (outside the U.S.). The Conference ID for the replay is 11336 followed by the #

key. To access the replay of the conference call via the internet, visit the MetLife Investor

Relations webpage (https://investor.metlife.com).

###

Page 8 of 26

Non-GAAP and Other Financial Disclosures

Any references in this news release (except in this section and the tables that accompany this release) to:			Should be read as, respectively:
(i)	net income (loss)		(i)	net income (loss) available to MetLife, Inc.’s common shareholders
(ii)	net income (loss) per share		(ii)	net income (loss) available to MetLife, Inc.’s common shareholders per diluted common share
(iii)	adjusted earnings		(iii)	adjusted earnings available to common shareholders
(iv)	adjusted earnings per share		(iv)	adjusted earnings available to common shareholders per diluted common share
(v)	book value per share		(v)	book value per common share
(vi)	adjusted book value per share		(vi)	adjusted book value per common share
(vii)	return on equity		(vii)	return on MetLife, Inc.’s common stockholders’ equity
(viii)	adjusted return on equity		(viii)	adjusted return on MetLife, Inc.’s common stockholders’ equity

In this news release, MetLife presents certain measures of its performance on a consolidated and

segment basis that are not calculated in accordance with accounting principles generally accepted in the

United States of America (GAAP). MetLife believes that these non-GAAP financial measures enhance our

investors’ understanding of MetLife’s performance by highlighting the results of operations and the

underlying profitability drivers of the business. Segment-specific financial measures are calculated using

only the portion of consolidated results attributable to that specific segment.

The following non-GAAP financial measures should not be viewed as substitutes for the most directly

comparable financial measures calculated in accordance with GAAP:

Non-GAAP financial measures:			Comparable GAAP financial measures:
(i)	total adjusted revenues		(i)	total revenues
(ii)	total adjusted expenses		(ii)	total expenses
(iii)	adjusted premiums, fees and other revenues		(iii)	premiums, fees and other revenues
(iv)	adjusted premiums, fees and other revenues, excluding PRT		(iv)	premiums, fees and other revenues
(v)	adjusted net investment income		(v)	net investment income
(vi)	adjusted earnings available to common shareholders		(vi)	net income (loss) available to MetLife, Inc.’s common shareholders
(vii)	adjusted earnings available to common shareholders, excluding total notable items		(vii)	net income (loss) available to MetLife, Inc.’s common shareholders
(viii)	adjusted earnings available to common shareholders per diluted common share		(viii)	net income (loss) available to MetLife, Inc.’s common shareholders per diluted common share
(ix)	adjusted earnings available to common shareholders, excluding total notable items, per diluted common share		(ix)	net income (loss) available to MetLife, Inc.’s common shareholders per diluted common share
(x)	adjusted return on equity		(x)	return on equity

Page 9 of 26

(xi)	adjusted return on equity, excluding total notable items		(xi)	return on equity
(xii)	investment portfolio gains (losses)		(xii)	net investment gains (losses)
(xiii)	derivative gains (losses)		(xiii)	net derivative gains (losses)
(xiv)	adjusted capitalization of deferred policy acquisition costs (DAC)		(xiv)	capitalization of DAC
(xv)	total MetLife, Inc.’s adjusted common stockholders’ equity		(xv)	total MetLife, Inc.’s stockholders’ equity
(xvi)	total MetLife, Inc.’s adjusted common stockholders’ equity, excluding total notable items		(xvi)	total MetLife, Inc.’s stockholders’ equity
(xvii)	adjusted book value per common share		(xvii)	book value per common share
(xviii)	adjusted other expenses		(xviii)	other expenses
(xix)	adjusted other expenses, net of adjusted capitalization of DAC		(xix)	other expenses, net of capitalization of DAC
(xx)	adjusted other expenses, net of adjusted capitalization of DAC, excluding total notable items related to adjusted other expenses		(xx)	other expenses, net of capitalization of DAC
(xxi)	adjusted expense ratio		(xxi)	expense ratio
(xxii)	adjusted expense ratio, excluding total notable items related to adjusted other expenses and PRT		(xxii)	expense ratio
(xxiii)	direct expenses		(xxiii)	other expenses
(xxiv)	direct expenses, excluding total notable items related to direct expenses		(xxiv)	other expenses
(xxv)	direct expense ratio		(xxv)	expense ratio
(xxvi)	direct expense ratio, excluding total notable items related to direct expenses and PRT		(xxvi)	expense ratio
(xxvii)	future policy benefits at original discount rate		(xxvii)	future policy benefits at balance sheet discount rate
(xxviii)	free cash flow of all holding companies		(xxviii)	MetLife, Inc. (parent company only) net cash provided by (used in) operating activities

Reconciliations of these non-GAAP measures to the most directly comparable GAAP measures are not

accessible on a forward-looking basis because we believe it is not possible without unreasonable effort to

provide other than a range of net investment gains and losses and net derivative gains and losses, which

can fluctuate significantly within or outside the range and from period to period and may have a material

impact on net income.

Any of these financial measures shown on a constant currency basis reflect the impact of changes in

foreign currency exchange rates and are calculated using the average foreign currency exchange rates

for the current period and applied to the comparable prior period (“constant currency basis”).

Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial

measures are included in this earnings news release and in this period’s quarterly financial supplement,

which is available at MetLife’s Investor Relations webpage (https://investor.metlife.com).

MetLife’s definitions of non-GAAP and other financial measures discussed in this news release may differ

from those used by other companies:

Adjusted earnings and related measures

•adjusted earnings;

Page 10 of 26

•adjusted earnings available to common shareholders;

•adjusted earnings available to common shareholders, on a constant currency basis;

•adjusted earnings available to common shareholders, excluding total notable items;

•adjusted earnings available to common shareholders, excluding total notable items, on a constant

currency basis;

•adjusted earnings available to common shareholders per diluted common share;

•adjusted earnings available to common shareholders, on a constant currency basis per diluted

common share;

•adjusted earnings available to common shareholders, excluding total notable items per diluted

common share; and

•adjusted earnings available to common shareholders, excluding total notable items, on a constant

currency basis per diluted common share.

Adjusted earnings is used by MetLife’s chief operating decision maker, its chief executive officer, to

evaluate performance and allocate resources. Consistent with GAAP guidance for segment reporting,

adjusted earnings is MetLife’s GAAP measure of segment performance. Adjusted earnings and related

measures based on adjusted earnings are also the measures by which senior management’s and many

other employees’ performance is evaluated for the purposes of determining their compensation under

applicable compensation plans. Adjusted earnings and related measures based on adjusted earnings

allow analysis of MetLife’s performance relative to its business plan and facilitate comparisons to industry

results.

Adjusted earnings is defined as adjusted revenues less adjusted expenses, net of income tax. Adjusted

earnings available to common shareholders is defined as adjusted earnings less preferred stock

dividends.

Adjusted earnings, along with the related adjusted revenues, adjusted expenses and adjusted premiums,

fees and other revenues, focus on our primary businesses principally by excluding the impact of (i) market

volatility which could distort trends, (ii) asymmetrical and non-economic accounting, (iii) revenues and

costs related to divested businesses, and (iv) other adjustments. Also, adjusted earnings and related

measures exclude results of discontinued operations under GAAP.

Market volatility can have a significant impact on MetLife’s financial results. Adjusted earnings excludes

net investment gains (losses), net derivative gains (losses), market risk benefit remeasurement gains

(losses) and goodwill impairments. Further, net investment income is adjusted to exclude similar items

relating to joint ventures accounted for under the equity method (“Joint venture adjustments”), and

policyholder benefits and claims exclude (i) changes in the discount rate on certain annuitization

guarantees accounted for as additional liabilities and (ii) market value adjustments.

Asymmetrical and non-economic accounting adjustments are made in calculating adjusted earnings:

•Universal life and investment-type product policy fees exclude asymmetrical accounting associated

with in-force reinsurance.

•Net investment income includes earned income on derivatives and amortization of premium on

derivatives that are hedges of investments or that are used to replicate certain investments, but do

not qualify for hedge accounting treatment (“Investment hedge adjustments”).

•Other revenues include settlements of foreign currency earnings hedges and exclude asymmetrical

accounting associated with in-force reinsurance.

•Policyholder benefits and claims excludes (i) inflation-indexed benefit adjustments associated with

contracts backed by inflation-indexed investments, (ii) asymmetrical accounting associated with in-

force reinsurance, and (iii) non-economic losses incurred at contract inception for certain single

premium annuity business. These losses are amortized into adjusted earnings within policyholder

benefits and claims over the estimated lives of the contracts.

•Policyholder liability remeasurement gains (losses) excludes asymmetrical accounting associated

with in-force reinsurance.

Page 11 of 26

•Interest credited to policyholder account balances excludes amounts associated with periodic

crediting rate adjustments based on the total return of a contractually referenced pool of assets and

other pass-through adjustments and asymmetrical accounting associated with in-force reinsurance.

“Divested businesses” are those that have been or will be sold or exited by MetLife but do not meet the

discontinued operations criteria under GAAP. Divested businesses also include the net impact of

transactions with exited businesses that have been eliminated in consolidation under GAAP and costs

relating to businesses that have been or will be sold or exited by MetLife that do not meet the criteria to

be included in results of discontinued operations under GAAP.

Other adjustments are made in calculating adjusted earnings:

•Beginning in the fourth quarter of 2025, net investment income excludes depreciation of wholly-

owned real estate and real estate joint ventures.

•Net investment income and interest credited to policyholder account balances exclude certain

amounts related to contractholder-directed equity securities (“Unit-linked contract income” and

“Unit-linked contract costs”).

•Net investment income and other expenses exclude Reinsurance activity (as defined below).

•Net investment income and interest expense on debt exclude amounts related to collateralized

financing entities that are consolidated variable interest entities.

•Other revenues include fee revenue on synthetic guaranteed interest contracts (“GICs”) accounted

for as freestanding derivatives.

•Other expenses exclude (i) amortization and impairment of asset management intangible assets,

(ii) implementation of new insurance regulatory requirements and other costs, and (iii) acquisition,

integration and other related costs. Other expenses include (i) deductions for net income

attributable to noncontrolling interests and redeemable noncontrolling interests, and (ii) benefits

accrued on synthetic GICs accounted for as freestanding derivatives.

•“Reinsurance activity” relates to amounts subject to ceded reinsurance arrangements with third

parties and joint ventures, including (i) the related investment returns and expenses which are

passed through to the reinsurers and (ii) the corresponding invested assets and cash and cash

equivalents.

Adjusted earnings also excludes the recognition of certain contingent assets and liabilities that could not

be recognized at acquisition or adjusted for during the measurement period under GAAP business

combination accounting guidance.

The tax impact of the adjustments mentioned above are calculated net of the U.S. or foreign statutory tax

rate, which could differ from MetLife’s effective tax rate. Additionally, the provision for income tax

(expense) benefit also includes the impact related to the timing of certain tax credits, as well as certain tax

reforms.

In addition, adjusted earnings available to common shareholders excludes the impact of preferred stock

redemption premium, which is reported as a reduction to net income (loss) available to MetLife, Inc.’s

common shareholders.

Investment portfolio gains (losses) and derivative gains (losses)

These are measures of investment and hedging activity. Investment portfolio gains (losses) principally

excludes amounts that are reported within net investment gains (losses) but do not relate to the

performance of the investment portfolio, such as gains (losses) on sales and divestitures of businesses,

as well as investment portfolio gains (losses) of divested businesses. Derivative gains (losses) principally

excludes earned income on derivatives and amortization of premium on derivatives, where such

derivatives are either hedges of investments or are used to replicate certain investments, and where such

derivatives do not qualify for hedge accounting. This earned income and amortization of premium is

reported within adjusted earnings and not within derivative gains (losses).

Page 12 of 26

Return on equity and related measures

•Total MetLife, Inc.’s adjusted common stockholders’ equity: total MetLife, Inc.’s common

stockholders’ equity, excluding unrealized investment gains (losses), net of related offsets, deferred

gains (losses) on derivatives, future policy benefits discount rate remeasurement gains (losses),

market risk benefits instrument-specific credit risk remeasurement gains (losses) and defined benefit

plans adjustment components of accumulated other comprehensive income (loss) (“AOCI”) and the

estimated fair value of certain ceded reinsurance-related embedded derivatives, all net of income

tax.

•Total MetLife, Inc.’s adjusted common stockholders’ equity, excluding total notable items: total

MetLife, Inc.’s common stockholders’ equity, excluding unrealized investment gains (losses), net of

related offsets, deferred gains (losses) on derivatives, future policy benefits discount rate

remeasurement gains (losses), market risk benefits instrument-specific credit risk remeasurement

gains (losses) and defined benefit plans adjustment components of AOCI, the estimated fair value of

certain ceded reinsurance-related embedded derivatives and total notable items, all net of income

tax.

•Return on MetLife, Inc.’s common stockholders’ equity: net income (loss) available to MetLife, Inc.’s

common shareholders divided by MetLife, Inc.’s average common stockholders’ equity.

•Adjusted return on MetLife, Inc.’s common stockholders’ equity: adjusted earnings available to

common shareholders divided by MetLife, Inc.’s average adjusted common stockholders’ equity.

•Adjusted return on MetLife, Inc.’s common stockholders’ equity, excluding total notable items:

adjusted earnings available to common shareholders, excluding total notable items, divided by

MetLife, Inc.’s average adjusted common stockholders’ equity, excluding total notable items.

The above measures represent a level of equity that excludes most components of AOCI, such as

unrealized investment gains (losses), net of related offsets, and future policy benefits discount rate

remeasurement gains (losses), as well as the impact of certain ceded reinsurance-related embedded

derivatives, as these amounts are primarily driven by market volatility.

Expense ratio, direct expense ratio, adjusted expense ratio and related measures

•Expense ratio: other expenses, net of capitalization of DAC, divided by premiums, fees and other

revenues.

•Direct expense ratio: direct expenses divided by adjusted premiums, fees and other revenues. Direct

expenses are comprised of employee-related costs, third-party staffing costs, and general and

administrative expenses.

•Direct expense ratio, excluding total notable items related to direct expenses and PRT: direct

expenses, excluding total notable items related to direct expenses, divided by adjusted premiums,

fees and other revenues, excluding PRT.

•Adjusted expense ratio: adjusted other expenses, net of adjusted capitalization of DAC, divided by

adjusted premiums, fees and other revenues.

•Adjusted expense ratio, excluding total notable items related to adjusted other expenses and PRT:

adjusted other expenses, net of adjusted capitalization of DAC, excluding total notable items related

to adjusted other expenses, divided by adjusted premiums, fees and other revenues, excluding PRT.

Assets Under Management (“AUM”):

•Total Assets Under Management (“Total AUM”) is comprised of MIM GA AUM plus Institutional Client

AUM (each, as defined below).

•MIM General Account AUM (“MIM GA AUM”) is used by MetLife to describe the portion of GA AUM

(as defined below) that MetLife Investment Management, LLC and certain of its affiliates (“MIM”)

manages or advises.

Page 13 of 26

•General Account AUM (“GA AUM”) is used by MetLife to describe assets in its general account

(“GA”) investment portfolio. GA AUM is stated at estimated fair value and is comprised of GA total

investments, the portion of the GA investment portfolio classified within assets held-for-sale, cash

and cash equivalents, and accrued investment income on such assets, and excludes policy loans,

certain contractholder-directed equity securities, fair value option securities, mortgage loans

originated for third parties, assets subject to ceded reinsurance arrangements with third parties and

joint ventures, and certain other invested assets. Mortgage loans and real estate and real estate joint

ventures included in GA AUM (at net asset value, net of deduction for encumbering debt) have been

adjusted from carrying value to estimated fair value. Classification of GA AUM by sector is based on

the nature and characteristics of the underlying investments which can vary from how they are

classified under GAAP. Accordingly, the underlying investments within certain real estate and real

estate joint ventures that are primarily commercial mortgage loans (at net asset value, net of

deduction for encumbering debt) have been reclassified to exclude them from real estate and real

estate joint ventures and include them as commercial mortgage loans.

•Institutional Client AUM is comprised of SA AUM plus Reinsurance AUM plus TP AUM (each, as

defined below). MIM manages or advises Institutional Client AUM in accordance with client

guidelines contained in each investment advisory agreement.

◦Separate Account AUM (“SA AUM”) is comprised of separate account investment portfolios, which

are managed or advised by MIM and included in MetLife, Inc.’s consolidated financial statements

at estimated fair value, as well as accrued investment income on such assets.

◦Reinsurance AUM is comprised of GA assets subject to ceded reinsurance arrangements with

third parties and joint ventures, which are managed or advised by MIM and are generally included

in MetLife, Inc.’s consolidated financial statements at estimated fair value, as well as accrued

investment income on such assets.

◦Third-Party AUM (“TP AUM”) is comprised of non-proprietary assets managed or advised by MIM

on behalf of unaffiliated/third-party clients, which are stated at estimated fair value, as well as

accrued investment income on such assets. Such non-proprietary assets are owned by

unaffiliated/third-party clients and, accordingly, are generally not included in MetLife, Inc.’s

consolidated financial statements.

•Asia General Account AUM (“Asia GA AUM”) is used by MetLife to describe assets in its Asia GA

investment portfolio. Asia GA AUM is stated at estimated fair value and is comprised of Asia GA total

investments, the portion of the Asia GA investment portfolio classified within assets held-for-sale,

cash and cash equivalents, and accrued investment income on such assets, and excludes policy

loans, certain contractholder-directed equity securities, fair value option securities, mortgage loans

originated for third parties, assets subject to ceded reinsurance arrangements with third parties and

joint ventures, and certain other invested assets. Mortgage loans and real estate and real estate joint

ventures included in Asia GA AUM (at net asset value, net of deduction for encumbering debt) have

been adjusted from carrying value to estimated fair value. At the segment level, intersegment

balances (intercompany activity, primarily related to investments in subsidiaries, that eliminate at the

MetLife consolidated level) are excluded from Asia GA AUM.

Asia GA AUM (at amortized cost) excludes the following adjustments: (i) unrealized gain (loss) on

investments carried at estimated fair value and (ii) adjustments from carrying value to estimated fair

value on mortgage loans and real estate and real estate joint ventures. Asia GA AUM (at amortized

cost) is presented net of related allowance for credit loss.

Other items

The following additional information is relevant to an understanding of MetLife’s performance:

•Statistical sales information:

•Group Benefits: calculated using 10% of single premium deposits and 100% of annualized full-

year premiums and fees from recurring premium policy sales of all products.

Page 14 of 26

•RIS: calculated using 10% of single premium contracts, on and off-balance sheet deposits, and

the contract value for new U.K. longevity reinsurance contracts, and 100% of annualized full-year

premiums and fees only from recurring premium policy sales of specialized benefit resources and

corporate-owned life insurance.

•Asia, Latin America and EMEA: calculated using 10% of single premium deposits (mainly from

retirement products such as variable annuity, fixed annuity and pensions), 20% of single premium

deposits from credit insurance and 100% of annualized full-year premiums and fees from

recurring-premium policy sales of all products (mainly from risk and protection products such as

individual life, accident & health and group).

Sales statistics do not correspond to revenues under GAAP, but are used as relevant measures of

business activity.

•Volume growth, where cited, represents the change in certain measures of our segment results,

including adjusted earnings, attributable to business growth, applying a model in which certain

margins and factors are held constant, the most significant of which are underwriting margins,

investment margins, changes in equity market performance, expense margins and the impact of

changes in foreign currency exchange rates.

•PRT includes U.K. funded reinsurance.

•Institutional net flows reflect Institutional Client AUM total fund additions less withdrawals.

•“Third-party mortgage loan activity” relates to amounts associated with mortgage loans originated

and acquired for third parties, including (i) the related investment returns and expenses which are

passed through to the third-party lenders and (ii) the corresponding mortgage loan assets.

•We refer to observable forward yield curves as of a particular date in connection with making our

estimates for future results. The observable forward yield curves at a given time are based on

implied future interest rates along a range of interest rate durations. This includes the 10-year U.S.

Treasury rate which we use as a benchmark rate to describe longer-term interest rates used in our

estimates for future results.

•Notable items reflect the unexpected impact of events that affect MetLife’s results, but that were

unknown and that MetLife could not anticipate when it devised its business plan. Notable items also

include certain items regardless of the extent anticipated in the business plan, to help investors have

a better understanding of MetLife’s results and to evaluate and forecast those results. Notable items

represent a positive (negative) impact to adjusted earnings available to common shareholders.

•Holding company cash and liquid assets are held by MetLife, Inc. collectively with other MetLife

holding companies and include cash and cash equivalents, short-term investments and publicly

traded securities excluding assets that are pledged or otherwise committed. Assets pledged or

otherwise committed include amounts received in connection with securities lending, repurchase

agreements, derivatives, regulatory deposits, the collateral financing arrangement, funding

agreements and secured borrowings, as well as amounts held in the closed block.

•MetLife uses a measure of free cash flow to facilitate an understanding of its ability to generate cash

for reinvestment into its businesses or use in non-mandatory capital actions. MetLife defines free

cash flow as the sum of cash available at MetLife’s holding companies from dividends from operating

subsidiaries, expenses and other net flows of the holding companies (including capital contributions

to subsidiaries), and net contributions from debt to be at or below target leverage ratios. This

measure of free cash flow is prior to capital actions, such as common stock dividends and

repurchases, debt reduction and mergers and acquisitions. Free cash flow should not be viewed as

a substitute for net cash provided by (used in) operating activities calculated in accordance with

GAAP. The free cash flow ratio is typically expressed as a percentage of annual adjusted earnings

available to common shareholders.

Page 15 of 26

Forward-Looking Statements

This news release may contain or incorporate by reference information that includes or is based upon

forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

Forward-looking statements give expectations or forecasts of future events and do not relate strictly to

historical or current facts. They use words and terms such as “anticipate,” “are confident,” “assume,”

“believe,” “continue,” “could,” “estimate,” “expect,” “if,” “intend,” “likely,” “may,” “plan,” “potential,” “project,”

“should,” “target,” “will,” “would,” and other words and terms of similar meaning or that are otherwise tied

to future periods or future performance, in each case in all derivative forms. They include statements

relating to strategy, goals and expectations concerning our market position, future operations, margins,

profitability, capital expenditures, liquidity and capital resources and other financial and operating

information. By their nature, forward-looking statements: speak only as of the date they are made; are not

statements of historical fact or guarantees of future performance; and are subject to risks, uncertainties,

assumptions or changes in circumstances that are difficult to predict or quantify. Our expectations, beliefs

and projections are expressed in good faith and we believe there is a reasonable basis for them.

However, there can be no assurance that management’s expectations, beliefs and projections will result

or be achieved and actual results may vary materially from what is expressed in or indicated by the

forward-looking statements.

Many factors determine the results of MetLife, Inc., its subsidiaries and affiliates, and they involve

unpredictable risks and uncertainties. Our forward-looking statements depend on our assumptions, our

expectations, and our understanding of the economic environment, but they may be inaccurate and may

change. MetLife, Inc. does not guarantee any future performance. Our results could differ materially from

those MetLife, Inc. expresses or implies in forward-looking statements. The risks, uncertainties and other

factors identified in MetLife, Inc.’s filings with the U.S. Securities and Exchange Commission, and others,

may cause such differences. These factors include:

(1)economic condition difficulties, including risks relating to interest rates, the effects of announced or

future tariff increases on the global economy, credit spreads, declining equity or debt markets,

changes in the value of assets under management, real estate, obligors and counterparties,

government default or shutdown, currency exchange rates, derivatives, climate change, public

health, terrorism and security;

(2)global capital and credit market adversity;

(3)credit facility inaccessibility;

(4)financial strength or credit ratings downgrades;

(5)unavailability, unaffordability, or inadequate reinsurance, including reinsurance risks that arise from

reinsurers’ credit risk, and the potential shortfall or failure of risk mitigants to protect against such

risks;

(6)statutory life insurance reserve financing costs or limited market capacity;

(7)legal, regulatory, and supervisory and enforcement policy changes;

(8)changes in tax rates, tax laws or interpretations;

(9)litigation and regulatory investigations;

(10)unsuccessful efforts to meet all sustainability standards or to enhance our sustainability;

(11)MetLife, Inc.’s inability to pay dividends and repurchase common stock;

(12)MetLife, Inc.’s subsidiaries’ inability to pay dividends to MetLife, Inc.;

(13)investment defaults, downgrades, or volatility;

(14)investment sales or lending difficulties;

(15)collateral or derivative-related payments;

(16)investment valuations, allowances, or impairments changes;

(17)claims or other results that differ from our estimates, assumptions, or models;

(18)global political, legal, or operational risks;

(19)business competition;

(20)technological changes;

(21)catastrophes;

(22)climate changes or responses to it;

(23)deficiencies in our closed block;

Page 16 of 26

(24)goodwill or other asset impairment, or deferred income tax asset allowance;

(25)impairment of VOBA, value of distribution agreements acquired or value of customer relationships

acquired;

(26)product guarantee volatility, costs, and counterparty risks;

(27)risk management failures;

(28)insufficient protection from operational risks;

(29)failure to protect confidentiality, integrity or availability of systems or data or other cybersecurity or

disaster recovery failures;

(30)accounting standards changes;

(31)excessive risk-taking;

(32)marketing and distribution difficulties;

(33)pension and other postretirement benefit assumption changes;

(34)inability to protect our intellectual property or avoid infringement claims;

(35)acquisition, integration, growth, disposition, or reorganization difficulties;

(36)Brighthouse Financial, Inc. separation risks;

(37)MetLife, Inc.’s Board of Directors influence over the outcome of stockholder votes through the

voting provisions of the MetLife Policyholder Trust; and

(38)legal- and corporate governance-related effects on business combinations.

MetLife, Inc. does not undertake any obligation to publicly correct or update any forward-looking

statement if MetLife, Inc. later becomes aware that such statement is not likely to be achieved. Please

consult any further disclosures MetLife, Inc. makes on related subjects in subsequent reports to the U.S.

Securities and Exchange Commission.

Page 17 of 26

MetLife, Inc.
GAAP Consolidated Statements of Operations
(In millions)
		For the Three Months Ended				For the Year Ended
		December 31,				December 31,
		2025		2024		2025		2024
Revenues
Premiums		$16,691		$12,617		$49,779		$44,945
Universal life and investment-type product policy fees		1,268		1,217		5,003		4,974
Net investment income		5,924		5,405		22,559		21,273
Other revenues		737		641		2,827		2,601
Net investment gains (losses)		(160)		(311)		(1,145)		(1,184)
Net derivative gains (losses)		(646)		(903)		(1,939)		(1,623)
Total revenues		23,814		18,666		77,084		70,986
Expenses
Policyholder benefits and claims		16,776		12,572		49,718		44,728
Policyholder liability remeasurement (gains) losses		35		(42)		(150)		(206)
Market risk benefit remeasurement (gains) losses		(267)		(764)		(508)		(1,109)
Interest credited to policyholder account balances		2,342		2,012		8,950		8,339
Policyholder dividends		129		150		553		595
Amortization of DAC, VOBA and negative VOBA		545		517		2,114		2,021
Interest expense on debt		263		259		1,061		1,037
Other expenses, net of capitalization of DAC		2,874		2,581		10,685		9,959
Total expenses		22,697		17,285		72,423		65,364
Income (loss) before provision for income tax		1,117		1,381		4,661		5,622
Provision for income tax expense (benefit)		301		106		1,258		1,178
Net income (loss)		816		1,275		3,403		4,444
Less: Net income (loss) attributable to noncontrolling interests and redeemable noncontrolling interests		7		4		24		18
Net income (loss) attributable to MetLife, Inc.		809		1,271		3,379		4,426
Less: Preferred stock dividends		31		32		194		200
Preferred stock redemption premium		—		—		12		—
Net income (loss) available to MetLife, Inc.'s common shareholders		$778		$1,239		$3,173		$4,226
See footnotes on last page.

Page 18 of 26

MetLife, Inc.
(In millions, except per share data)
		For the Three Months Ended								For the Year Ended
		December 31,								December 31,
		2025				2024				2025				2024
Reconciliation to Adjusted Earnings Available to Common Shareholders				Earnings Per Weighted Average Common Share Diluted (1)				Earnings Per Weighted Average Common Share Diluted (1)				Earnings Per Weighted Average Common Share Diluted (1)				Earnings Per Weighted Average Common Share Diluted (1)
Net income (loss) available to MetLife, Inc.'s common shareholders		$778		$1.17		$1,239		$1.78		$3,173		$4.71		$4,226		$5.94
Adjustments from net income (loss) available to common shareholders to adjusted earnings available to common shareholders:
Less: Net investment gains (losses)		(160)		(0.24)		(311)		(0.45)		(1,145)		(1.70)		(1,184)		(1.67)
Net derivative gains (losses)		(646)		(0.98)		(903)		(1.29)		(1,939)		(2.88)		(1,623)		(2.28)
Market risk benefit remeasurement gains (losses)		267		0.40		764		1.09		508		0.75		1,109		1.56
Goodwill impairment		—		—		—		—		—		—		—		—
Other adjustments to net income (loss)		(514)		(0.78)		(118)		(0.15)		(789)		(1.17)		(541)		(0.76)
Provision for income tax (expense) benefit		190		0.29		352		0.50		631		0.94		687		0.97
Add: Net income (loss) attributable to noncontrolling interests and redeemable noncontrolling interests		7		0.01		4		0.01		24		0.04		18		0.03
Preferred stock redemption premium		—		—		—		—		12		0.02		—		—
Adjusted earnings available to common shareholders		1,648		2.49		1,459		2.09		5,943		8.83		5,796		8.15
Less: Total notable items		(61)		(0.09)		10		0.01		(43)		(0.06)		26		0.04
Adjusted earnings available to common shareholders, excluding total notable items		$1,709		$2.58		$1,449		$2.08		$5,986		$8.89		$5,770		$8.11
Adjusted earnings available to common shareholders on a constant currency basis		$1,648		$2.49		$1,473		$2.11		$5,943		$8.83		$5,742		$8.07
Adjusted earnings available to common shareholders, excluding total notable items, on a constant currency basis		$1,709		$2.58		$1,463		$2.10		$5,986		$8.89		$5,716		$8.04
Weighted average common shares outstanding - diluted				662.2				697.9				673.3				711.1
See footnotes on last page.

Page 19 of 26

MetLife, Inc.
(In millions)
	For the Three Months Ended				For the Year Ended
	December 31,				December 31,
	2025		2024		2025		2024
Premiums, Fees and Other Revenues
Premiums, fees and other revenues	$18,696		$14,475		$57,609		$52,520
Less: Adjustments to premiums, fees and other revenues:
Asymmetrical and non-economic accounting	100		34		256		158
Other	(17)		(11)		(63)		(48)
Divested businesses	(1)		15		8		31
Adjusted premiums, fees and other revenues	$18,614		$14,437		$57,408		$52,379
Adjusted premiums, fees and other revenues, on a constant currency basis	$18,614		$14,545		$57,408		$52,178
Less: PRT	5,775		2,593		7,569		4,849
Adjusted premiums, fees and other revenues, excluding PRT, on a constant currency basis	$12,839		$11,952		$49,839		$47,329
Net Investment Income
Net investment income	$5,924		$5,405		$22,559		$21,273
Less: Adjustments to net investment income:
Investment hedge adjustments	(105)		(127)		(410)		(604)
Depreciation of wholly-owned real estate and real estate joint ventures	(72)				(72)
Joint venture adjustments	(64)		16		(98)		82
Unit-linked contract income	366		183		1,217		1,091
Reinsurance activity	222		31		489		31
Divested businesses	—		1		1		1
Adjusted net investment income	$5,577		$5,301		$21,432		$20,672
Revenues and Expenses
Total revenues	$23,814		$18,666		$77,084		$70,986
Less: Adjustments to total revenues:
Net investment gains (losses)	(160)		(311)		(1,145)		(1,184)
Net derivative gains (losses)	(646)		(903)		(1,939)		(1,623)
Investment hedge adjustments	(105)		(127)		(410)		(604)
Depreciation of wholly-owned real estate and real estate joint ventures	(72)				(72)
Asymmetrical and non-economic accounting, excluding Investment hedge adjustments	100		34		256		158
Unit-linked contract costs	366		183		1,217		1,091
Reinsurance activity	222		31		489		31
Other	(81)		5		(161)		34
Divested businesses	(1)		16		9		32
Total adjusted revenues	$24,191		$19,738		$78,840		$73,051
Total expenses	$22,697		$17,285		$72,423		$65,364
Less: Adjustments to total expenses:
Market risk benefit remeasurement (gains) losses	(267)		(764)		(508)		(1,109)
Goodwill impairment	—		—		—		—
Asymmetrical and non-economic accounting	458		46		646		322
Market volatility	(76)		(49)		(209)		(256)
Unit-linked contract costs	366		185		1,196		1,081
Reinsurance activity	166		30		388		30
Other	15		25		57		49
Divested businesses	14		23		39		57
Total adjusted expenses	$22,021		$17,789		$70,814		$65,190
See footnotes on last page.

Page 20 of 26

MetLife, Inc.
(In millions, except per share and ratio data)
		For the Three Months Ended				For the Year Ended
		December 31,				December 31,
		2025		2024		2025		2024
Expense Detail and Ratios
Reconciliation of Capitalization of DAC to Adjusted Capitalization of DAC
Capitalization of DAC		$(882)		$(719)		$(3,219)		$(2,833)
Less: Divested businesses		—		—		—		—
Adjusted capitalization of DAC		$(882)		$(719)		$(3,219)		$(2,833)
Reconciliation of Other Expenses to Adjusted Other Expenses
Other expenses		$3,756		$3,300		$13,904		$12,792
Less: Reinsurance activity		166		30		388		30
Less: Other adjustments, excluding reinsurance activity		15		25		57		49
Less: Divested businesses		12		13		36		38
Adjusted other expenses		$3,563		$3,232		$13,423		$12,675
Other Detail and Ratios
Other expenses, net of capitalization of DAC		$2,874		$2,581		$10,685		$9,959
Premiums, fees and other revenues		$18,696		$14,475		$57,609		$52,520
Expense ratio		15.4%		17.8%		18.5%		19.0%
Direct expenses		$1,528		$1,396		$5,875		$5,611
Less: Total notable items related to direct expenses		40		(152)		40		(152)
Direct expenses, excluding total notable items related to direct expenses		$1,488		$1,548		$5,835		$5,763
Adjusted other expenses		$3,563		$3,232		$13,423		$12,675
Adjusted capitalization of DAC		(882)		(719)		(3,219)		(2,833)
Adjusted other expenses, net of adjusted capitalization of DAC		2,681		2,513		10,204		9,842
Less: Total notable items related to adjusted other expenses		81		(85)		183		(85)
Adjusted other expenses, net of adjusted capitalization of DAC, excluding total notable items related to adjusted other expenses		$2,600		$2,598		$10,021		$9,927
Adjusted premiums, fees and other revenues		$18,614		$14,437		$57,408		$52,379
Less: PRT		5,775		2,593		7,569		4,849
Adjusted premiums, fees and other revenues, excluding PRT		$12,839		$11,844		$49,839		$47,530
Direct expense ratio		8.2%		9.7%		10.2%		10.7%
Direct expense ratio, excluding total notable items related to direct expenses and PRT		11.6%		13.1%		11.7%		12.1%
Adjusted expense ratio		14.4%		17.4%		17.8%		18.8%
Adjusted expense ratio, excluding total notable items related to adjusted other expenses and PRT		20.3%		21.9%		20.1%		20.9%
See footnotes on last page.

Page 21 of 26

MetLife, Inc.
(In millions, except per share data)
		December 31,
Equity Details		2025		2024
Total MetLife, Inc.'s stockholders' equity		$28,398		$27,445
Less: Preferred stock		2,830		3,818
MetLife, Inc.'s common stockholders' equity		25,568		23,627
Less: Unrealized investment gains (losses), net of related offsets and income tax		(15,614)		(19,402)
Deferred gains (losses) on derivatives, net of income tax		(1,588)		370
Future policy benefits discount rate remeasurement gain (losses), net of income tax		6,871		6,529
Market risk benefits instrument-specific credit risk remeasurement gains (losses), net of income tax		(97)		(71)
Defined benefit plans adjustment, net of income tax		(1,393)		(1,442)
Estimated fair value of certain ceded reinsurance-related embedded derivatives, net of income tax		(8)		(129)
Total MetLife, Inc.'s adjusted common stockholders' equity		37,397		37,772
Less: Accumulated year-to-date total notable items, net of income tax		(43)		26
Total MetLife, Inc.'s adjusted common stockholders' equity, excluding total notable items		$37,440		$37,746
		December 31,
Book Value (2)		2025		2024
Book value per common share		39.02		34.28
Less: Unrealized investment gains (losses), net of related offsets and income tax		(23.83)		(28.15)
Deferred gains (losses) on derivatives, net of income tax		(2.42)		0.54
Future policy benefits discount rate remeasurement gain (losses), net of income tax		10.49		9.46
Market risk benefits instrument-specific credit risk remeasurement gains (losses), net of income tax		(0.15)		(0.10)
Defined benefit plans adjustment, net of income tax		(2.13)		(2.09)
Estimated fair value of certain ceded reinsurance-related embedded derivatives, net of income tax		(0.01)		(0.19)
Adjusted book value per common share		$57.07		$54.81
Common shares outstanding, end of period (3)		655.3		689.2

		For the Three Months Ended				For the Year Ended
		December 31, (4)				December 31,
Return on Equity		2025		2024		2025		2024
Return on MetLife, Inc.'s:
Common stockholders' equity		12.0%		19.6%		12.9%		16.9%
Adjusted return on MetLife, Inc.'s:
Adjusted common stockholders' equity		17.6%		15.4%		15.9%		15.2%
Adjusted common stockholders' equity, excluding total notable items		18.3%		15.3%		16.0%		15.2%
		For the Three Months Ended				For the Year Ended
		December 31,				December 31,
Average Common Stockholders' Equity		2025		2024		2025		2024
Average common stockholders' equity		$25,841		$25,347		$24,570		$25,008
Average adjusted common stockholders' equity		$37,385		$37,867		$37,415		$38,084
Average adjusted common stockholders' equity, excluding total notable items		$37,398		$37,846		$37,420		$38,076
See footnotes on last page.

Page 22 of 26

MetLife, Inc.
Adjusted Earnings Available to Common Shareholders
(In millions)
			For the Three Months Ended				For the Year Ended
			December 31,				December 31,
			2025		2024		2025		2024
Group Benefits (5):
	Adjusted earnings available to common shareholders		$465		$416		$1,692		$1,606
	Less: Total notable items		—		—		(2)		(58)
	Adjusted earnings available to common shareholders, excluding total notable items		$465		$416		$1,694		$1,664
	Adjusted premiums, fees and other revenues		$6,287		$6,184		$25,469		$24,870
RIS (5):
	Adjusted earnings available to common shareholders		$454		$386		$1,671		$1,667
	Less: Total notable items		—		—		13		104
	Adjusted earnings available to common shareholders, excluding total notable items		$454		$386		$1,658		$1,563
	Adjusted premiums, fees and other revenues		$7,209		$3,620		$12,262		$8,594
	Less: PRT		5,775		2,593		7,569		4,849
	Adjusted premiums, fees and other revenues, excluding PRT		$1,434		$1,027		$4,693		$3,745
Asia:
	Adjusted earnings available to common shareholders		$444		$443		$1,702		$1,621
	Less: Total notable items		—		—		70		(41)
	Adjusted earnings available to common shareholders, excluding total notable items		$444		$443		$1,632		$1,662
	Adjusted earnings available to common shareholders on a constant currency basis		$444		$440		$1,702		$1,605
	Adjusted earnings available to common shareholders, excluding total notable items, on a constant currency basis		$444		$440		$1,632		$1,646
	Adjusted premiums, fees and other revenues		$1,671		$1,635		$6,768		$6,757
	Adjusted premiums, fees and other revenues, on a constant currency basis		$1,671		$1,615		$6,768		$6,723
Latin America:
	Adjusted earnings available to common shareholders		$198		$201		$798		$881
	Less: Total notable items		(29)		—		(104)		4
	Adjusted earnings available to common shareholders, excluding total notable items		$227		$201		$902		$877
	Adjusted earnings available to common shareholders on a constant currency basis		$198		$218		$798		$846
	Adjusted earnings available to common shareholders, excluding total notable items, on a constant currency basis		$227		$218		$902		$842
	Adjusted premiums, fees and other revenues		$1,796		$1,438		$6,606		$5,936
	Adjusted premiums, fees and other revenues, on a constant currency basis		$1,796		$1,545		$6,606		$5,751
See footnotes on last page.

Page 23 of 26

MetLife, Inc.
Adjusted Earnings Available to Common Shareholders (Continued)
(In millions)
			For the Three Months Ended				For the Year Ended
			December 31,				December 31,
			2025		2024		2025		2024
EMEA:
	Adjusted earnings available to common shareholders		$97		$59		$367		$283
	Less: Total notable items		—		—		(1)		(5)
	Adjusted earnings available to common shareholders, excluding total notable items		$97		$59		$368		$288
	Adjusted earnings available to common shareholders on a constant currency basis		$97		$59		$367		$280
	Adjusted earnings available to common shareholders, excluding total notable items, on a constant currency basis		$97		$59		$368		$285
	Adjusted premiums, fees and other revenues		$787		$652		$2,901		$2,548
	Adjusted premiums, fees and other revenues, on a constant currency basis		$787		$673		$2,901		$2,566
MIM (5):
	Adjusted earnings available to common shareholders		$60		$16		$200		$55
	Less: Total notable items		—		—		—		—
	Adjusted earnings available to common shareholders, excluding total notable items		$60		$16		$200		$55
Corporate & Other (5):
	Adjusted earnings available to common shareholders		$(70)		$(62)		$(487)		$(317)
	Less: Total notable items		(32)		10		(19)		22
	Adjusted earnings available to common shareholders, excluding total notable items		$(38)		$(72)		$(468)		$(339)
	Adjusted premiums, fees and other revenues		$625		$727		$2,470		$2,956
See footnotes on last page.

Page 24 of 26

MetLife, Inc.
		For the Three Months Ended								For the Year Ended
		March 31, 2025		June 30, 2025		September 30, 2025		December 31, 2025		December 31, 2025		December 31, 2025
Variable investment income (post-tax, in millions) (6)												Assets ($ in billions)
Group Benefits		$3		$3		$5		$13		$24		$0.2
RIS		99		60		146		135		440		5.5
Asia		94		64		139		145		442		8.4
Latin America		3		7		2		6		18		0.3
EMEA		—		—		—		1		1		—
MIM		—		—		—		—		—		—
Corporate & Other		59		20		90		93		262		4.5
Total		$258		$154		$382		$393		$1,187		$18.9
See footnotes on last page.

Page 25 of 26

Condensed Reconciliation of Net Cash Provided by Operating Activities of MetLife, Inc.
to Free Cash Flow of All Holding Companies
(In billions, except ratios)
		For the Year Ended December 31,
		2025		2024
MetLife, Inc. (parent company only) net cash provided by operating activities		$2.8		$4.7
Adjustments from net cash provided by operating activities to free cash flow:
Add: Incremental debt to be at or below target leverage ratios		0.4		—
Add: Adjustments from net cash provided by operating activities to free cash flow (7)		0.5		(0.1)
MetLife, Inc. (parent company only) free cash flow		3.7		4.6
Other MetLife, Inc. holding companies free cash flow (8)		1.2		—
Free cash flow of all holding companies		$4.9		$4.6
Ratio of net cash provided by operating activities to consolidated net income (loss) available to MetLife, Inc.'s common shareholders:
MetLife, Inc. (parent company only) net cash provided by operating activities		$2.8		$4.7
Consolidated net income (loss) available to MetLife, Inc.'s common shareholders		$3.2		$4.2
Ratio of net cash provided by operating activities (parent company only) to consolidated net income (loss) available to MetLife, Inc.'s common shareholders (9)		90%		112%
Ratio of free cash flow to adjusted earnings available to common shareholders:
Free cash flow of all holding companies (10)		$4.9		$4.6
Consolidated adjusted earnings available to common shareholders (10)		$5.9		$5.8
Ratio of free cash flow of all holding companies to consolidated adjusted earnings available to common shareholders (10)		82%		79%
See footnotes on last page.

Page 26 of 26

MetLife, Inc.
		December 31, 2025
Cash & Capital (11), (12), (13) (in billions)
Holding Companies Cash & Liquid Assets				$3.6
Footnotes
(1)	Adjusted earnings available to common shareholders, excluding total notable items, per diluted common share is calculated on a standalone basis and may not equal (i) adjusted earnings available to common shareholders per diluted common share, less (ii) total notable items per diluted common share.
(2)	Book values exclude $2,830 million and $3,818 million of equity related to preferred stock at December 31, 2025 and December 31, 2024, respectively.
(3)	There were share repurchases of approximately $0.4 billion and $2.9 billion for the three months and year ended December 31, 2025, respectively. There were share repurchases of approximately $200 million in January 2026.
(4)	Annualized using quarter-to-date results.
(5)	Results on a constant currency basis are not included as constant currency impact is not significant.
(6)	Assumes a 21% tax rate.
(7)	Adjustments include: (i) capital contributions to subsidiaries; (ii) returns of capital from subsidiaries; (iii) repayments (issuances) of loans to subsidiaries, net; and (iv) investment portfolio and derivative changes and other, net.
(8)	Components include: (i) dividends and returns of capital from subsidiaries; (ii) capital contributions to subsidiaries; (iii) repayments (issuances) of loans to subsidiaries, net; (iv) other expenses; (v) dividends and returns of capital to MetLife, Inc. and (vi) investment portfolio and derivative changes and other, net.
(9)	Including the free cash flow of other MetLife, Inc. holding companies of $1.2 billion and $0 for the years ended December 31, 2025 and 2024, respectively, in the numerator of the ratio, this ratio, as adjusted, would be 126% and 112%, respectively.
(10)	i) Consolidated adjusted earnings available to common shareholders for the year ended December 31, 2025, was negatively impacted by notable items, primarily related to tax adjustments of ($0.1) billion, net of income tax, and litigation reserves and settlement costs of ($0.03) billion, net of income tax, offset by actuarial assumption review and other insurance adjustments of $0.09 billion, net of income tax. Excluding these notable items from the denominator of the ratio, the adjusted free cash flow ratio for 2025, would be 82%. ii) Consolidated adjusted earnings available to common shareholders for the year ended December 31, 2024, was positively impacted by notable items, primarily related to tax adjustments of $0.1 billion, net of income tax, and actuarial assumption review and other insurance adjustments of $0.02 billion, net of income tax, offset by litigation reserves and settlement costs of ($0.05) billion, net of income tax. Excluding these notable items from the denominator of the ratio, the adjusted free cash flow ratio for 2024, would be 79%.
(11)	The 2025 combined U.S. risk based capital (RBC) ratio is estimated to be above MetLife's 360% target on an NAIC basis. This ratio includes MetLife, Inc.'s principal U.S. insurance subsidiaries, excluding American Life Insurance Company. MetLife calculates RBC annually as of December 31 and, accordingly, the calculation does not reflect conditions and factors occurring after the year end.
(12)	The total U.S. statutory adjusted capital, on a National Association of Insurance Commissioners basis, is expected to be approximately $17.2 billion at December 31, 2025, up 1%  from $17.1 billion at September 30, 2025. This balance includes MetLife, Inc.'s principal U.S. insurance subsidiaries, excluding American Life Insurance Company.
(13)	The expected Japan solvency margin ratio at December 31, 2025 is approximately 770%.